scholarly article | Q13442814 |
P356 | DOI | 10.4269/AJTMH.1984.33.197 |
P698 | PubMed publication ID | 6370001 |
P2093 | author name string | Williams JL | |
Haynes JD | |||
J. D. Haynes | |||
Diggs CL | |||
Vernes A | |||
J. L. Williams | |||
A. Vernes | |||
Dutoit E | |||
Tapchaisri P | |||
C. L. Diggs | |||
P. Tapchaisri | |||
E. Dutoit | |||
P433 | issue | 2 | |
P407 | language of work or name | English | Q1860 |
P921 | main subject | merozoite | Q2296434 |
Plasmodium falciparum | Q311383 | ||
erythrocyte invasion | Q122665572 | ||
merozoite invasion | Q123944667 | ||
P1104 | number of pages | 7 | |
P304 | page(s) | 197-203 | |
P577 | publication date | 1984-03-01 | |
P1433 | published in | American Journal of Tropical Medicine and Hygiene | Q15766943 |
P1476 | title | Plasmodium Falciparum Strain-Specific Human Antibody Inhibits Merozoite Invasion of Erythrocytes * | |
Plasmodium falciparum strain-specific human antibody inhibits merozoite invasion of erythrocytes | |||
P478 | volume | 33 |
Q24643787 | A malaria invasion receptor, the 175-kilodalton erythrocyte binding antigen of Plasmodium falciparum recognizes the terminal Neu5Ac(alpha 2-3)Gal- sequences of glycophorin A |
Q39516438 | A recombinant baculovirus-expressed Plasmodium falciparum receptor-binding domain of erythrocyte binding protein EBA-175 biologically mimics native protein. |
Q37223728 | Absence of antigenic diversity in Pf155, a major parasite antigen in membranes of erythrocytes infected with Plasmodium falciparum |
Q39515040 | Antibodies against the Plasmodium falciparum receptor binding domain of EBA-175 block invasion pathways that do not involve sialic acids |
Q43690388 | Binding of Plasmodium falciparum 175-kilodalton erythrocyte binding antigen and invasion of murine erythrocytes requires N-acetylneuraminic acid but not its O-acetylated form |
Q59138081 | Characterization of a Protein Phosphatase Type-1 and a Kinase Anchoring Protein in |
Q33755404 | Characterization of protective epitopes in a highly conserved Plasmodium falciparum antigenic protein containing repeats of acidic and basic residues. |
Q28741027 | Delineation of stage specific expression of Plasmodium falciparum EBA-175 by biologically functional region II monoclonal antibodies |
Q37235685 | Determination of genetic variation within Plasmodium falciparum by using enzymatically amplified DNA from filter paper disks impregnated with whole blood |
Q35042128 | Epitope map and processing scheme for the 195,000-dalton surface glycoprotein of Plasmodium falciparum merozoites deduced from cloned overlapping segments of the gene |
Q38314731 | Evidence for two-stage binding by the 175-kD erythrocyte binding antigen of Plasmodium falciparum |
Q72314521 | H-2b restriction of the immune response to the p126 Plasmodium falciparum antigen |
Q27973366 | Identification of Plasmodium falciparum Translation Initiation eIF2β Subunit: Direct Interaction with Protein Phosphatase Type 1 |
Q33608668 | Immunogenicity of the Plasmodium falciparum serine repeat antigen (p126) expressed by vaccinia virus. |
Q37141041 | Immunological characteristics of malaria antibodies in two regions of Madagascar |
Q41914622 | In vitro growth and chloroquine sensitivity of Plasmodium falciparum (FCR-3 strain) in red blood cells containing HbC. |
Q44409588 | Influence of medium osmolality on the in vitro growth of Plasmodium falciparum: a morphologic and radioisotopic study |
Q36352701 | Invasion of mouse erythrocytes by the human malaria parasite, Plasmodium falciparum |
Q35042373 | Microscopic and flow cytophotometric analysis of parasitemia in cultures of Plasmodium falciparum vitally stained with Hoechst 33342--application to studies of antimalarial agents |
Q27974345 | PhosphoTyrosyl phosphatase activator of Plasmodium falciparum: identification of its residues involved in binding to and activation of PP2A |
Q27972565 | Plasmodium falciparum dynein light chain 1 interacts with actin/myosin during blood stage development |
Q30038953 | Plasmodium falciparum encodes a conserved active inhibitor-2 for Protein Phosphatase type 1: perspectives for novel anti-plasmodial therapy |
Q27973484 | Plasmodium falciparum inhibitor-3 homolog increases protein phosphatase type 1 activity and is essential for parasitic survival |
Q92664225 | Plasmodium falciparum merozoite surface antigen-specific cytophilic IgG and control of malaria infection in a Beninese birth cohort |
Q36349756 | Polymorphism of a high molecular weight schizont antigen of the human malaria parasite Plasmodium falciparum |
Q42129581 | Primary structure of the 175K Plasmodium falciparum erythrocyte binding antigen and identification of a peptide which elicits antibodies that inhibit malaria merozoite invasion |
Q36943106 | Roles of conserved and allelic regions of the major merozoite surface protein (gp195) in immunity against Plasmodium falciparum |
Q36875983 | Serotypes of Plasmodium falciparum defined by immune serum inhibition of in vitro growth |
Q33512926 | The quantity and quality of African children's IgG responses to merozoite surface antigens reflect protection against Plasmodium falciparum malaria |
Search more.